Green Asia Impex Ltd.
GAILSME
Overview
Green Asia Impex Limited sources, processes and sells/exporters frozen seafood and agri-commodities, primarily frozen shrimps and also dried chillies, serving B2B customers such as importers, distributors and food processors across India and several overseas markets. The company operates a shrimp processing unit in Unguturu (Andhra Pradesh) with block-freezing and IQF capability and a leased chilli processing facility in Guntur, and it relies largely on trader/commission-agent networks in AMC markets for raw material procurement while using in-house QA/QC and export-oriented certifications (e.g., HACCP, ISO 22000, FSSAI, FDA/GACC) to meet buyer and regulatory requirements.
Opening Date
Sep 24, 2026
Closing Date
Sep 28, 2026
Listing Date
Oct 01, 2026
IPO Type
SME
IPO Status
Upcoming
Issue Size
60.1 Cr
Fresh Issue
53.1 Cr
Offer for Sale
7 Cr
Price Band
₹85 - ₹90
Lot Size
1600
IPO Timeline
Financials
Revenue
Profit After Tax (PAT)
Use of IPO funds
Key Performance Indicator
P/E Ratio
8.91
EPS
10.1
ROE
50.16%
ROCE
20.62%
RONW
50.16%
Debt to Equity Ratio
2.9
PAT Margin
3.07%
EBITDA Margin
6.14%
P/B
6.45
Bull vs Bear
Bull case
- •
The company is investing in more processing and cold-chain capacity, which can lift long-term competitiveness by serving bigger orders and more product formats.
- •
Export-ready processes and certifications can reduce customer hesitation and help retain buyers, because food-safety compliance is hard and expensive to build.
- •
Adding more IQF and value-added capability targets changing customer needs, which matters because it can reduce dependence on basic block-frozen products.
Bear case
- •
China is 31.29% of revenue, so policy or demand shocks there could quickly hit sales and margins before the company can replace volumes elsewhere.
- •
The new facility depends on unplaced equipment orders and pending approvals, so delays or cost overruns could strain cash flows and postpone growth benefits.
- •
Biosecurity and disease risks in shrimp, plus cold-chain dependency, can disrupt operations and damage reputation through spoilage or product rejections.
Net takeaway
The long-term story is a shrimp-led exporter trying to scale processing capacity and move into more value-added formats, which could strengthen customer stickiness and competitiveness. But a lot has to go right: demand must stay steady across key markets like China, the new facility must be executed on time and within cost, and biosecurity and cold-chain controls must hold up. The main thing to monitor is whether capacity expansion translates into higher utilization without stretching working capital further.
Subscription Rate
Subscription data will be available once the IPO opens.

